Back to News
Market Impact: 0.2
RFK Jr. Deputy Nominee Firmly Backs Vaccines in Senate Hearing
Source: Bloomberg
Healthcare & BiotechManagement & Governance
President Donald Trump's nominee for the No. 2 role at the top US health agency strongly endorsed the safety of the measles vaccine. The position contrasts with vaccine doubts previously raised by Trump and Health Secretary Robert F. Kennedy Jr., signaling potential internal policy tension but limited immediate market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- The big questions remaining after Anthropic’s blockbuster IPO prospectus
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand